SWOG 1512 A Phase II and Pilot Trial of PD-1 Blockade with MK-3475 (Pembrolizumab) in Patients with Resectable or Unresectable Desmoplastic Melanoma (DM)

December 10, 2018
https://clinicaltrials.gov/ct2/show/NCT02775851
Cancer - Melanoma
Principal Investigator: Ding Wang, MD
CANCER, MELANOMA, DESMOPLASTIC
Accepting Participants